Evaluation of the safety and efficacy of once-weekly PEG/interferon alfa-2A (PEGASYS™) for chronic hepatitis C. A multinational, randomized study
Keyword(s):
2002 ◽
Vol 9
(5)
◽
pp. 346-353
◽
Keyword(s):
1999 ◽
Vol 135
(8)
◽
pp. 1000-1001
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 9
(2)
◽
pp. 156-160
◽
Keyword(s):
2009 ◽
Vol 17
(6)
◽
pp. 410-418
◽